On 8 June 2026, the European Medicines Agency (EMA) published the presentations from a joint workshop co-organised by the European Network of Paediatric Research at the European Medicines Agency (EnprEMA) and the Accelerating Clinical Trials in the EU (ACT EU) initiative. The workshop focused on paediatric clinical trials, aiming to improve the design, conduct, and efficiency of trials involving children. The published materials include slide decks and summaries covering topics such as innovative trial designs, patient engagement, and regulatory considerations specific to paediatric populations.
The workshop brought together regulators, researchers, industry representatives, and patient advocates to discuss challenges and opportunities in paediatric clinical research. Key themes included the need for age-appropriate formulations, ethical considerations in consent, and the use of real-world evidence to supplement trial data. The presentations also highlighted ongoing efforts to streamline trial approvals across EU member states and to foster collaboration between national competent authorities.
Stakeholder impact For pharmaceutical companies developing paediatric medicines, the workshop's emphasis on innovative trial designs and regulatory flexibility could reduce development costs and timelines. However, the call for increased patient engagement and age-appropriate formulations may require additional investment in trial infrastructure and patient recruitment. National health authorities stand to benefit from harmonised approaches to trial approval, potentially accelerating access to new treatments for children. Patient advocacy groups and paediatricians are likely to welcome the focus on ethical consent and the inclusion of children's voices in trial design, though concerns about data privacy and the burden of participation remain.
Institutional follow-up EMA has not announced a specific timeline for implementing the workshop's recommendations, but the agency is expected to incorporate feedback into upcoming guidance documents on paediatric clinical trials. The workshop aligns with the broader ACT EU initiative, which aims to make the EU a more attractive region for clinical research. Further workshops or public consultations may follow to refine the proposed approaches.
← Atlas › News › Health & Lifestyle